Article
Characterization of the UK anthrax vaccine and human immunogenicity
8 Sept 2020
Abstract excerpt
The manufacture of the UK Anthrax vaccine (AVP) focuses on the production of Protective Antigen (PA) from the Bacillus anthracis Sterne strain. Although used for decades, several of AVP’s fundamental properties are poorly understood, including its exact composition, the extent to which proteins other than PA may contribute to protection, and whether the degree of protection varies between individuals.This study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
